Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Emtricitabine, Rilpivirine And Tenofovir Disoproxil (Atc Code J05Ar08).

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102504176

  Document Type - Tender Notices

Description - Description: Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code (SGB V) for medicinal products containing the active ingredient combination of emtricitabine, rilpivirine and tenofovir dis oproxil (ATC code J05AR08) within the period from April 1, 2025 to March 31, 2027 with the possibility of concluding the contract at any time during the term (“open-house model”).local title:: Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Emtricitabin, Rilpivirin und Tenofovirdisoproxil (ATC-Code J05AR08).Contract Type: : Supplylocal description: : Abschluss eines

Gt Ref Id - 102504176

Deadline - Jan 25, 2027